Statement of Recognized Income and Expense

| MSEK |
2007 |
2006 |
| Translation difference in foreign operations |
–258 |
–867 |
| Net change in fair value of available-for-sale financial assets |
– |
–40 |
| Effective portion of changes in fair value of cash flow hedges |
38 |
– |
| Actuarial gains and losses related to pensions, incl. payroll tax |
–57 |
44 |
| Tax on items taken to/transferred from equity |
–5 |
–27 |
| Total transactions taken to equity, excluding transactions with |
|
|
| equity holders of the Parent |
–282 |
–891 |
| Profit for the period recognized in the income statement |
2,056 |
2,335 |
| Total income and expense recognized for the period, |
|
|
| excluding transactions with equity holders of the Parent |
1,773 |
1,443 |
| attributable to: |
|
|
| Equity holders of the Parent |
1,772 |
1,443 |
| Minority interest |
1 |
1 |
| |
|
|
| The effect of the change in the accounting principle as per January 1, 2007 are specified in the table below: |
|
|
| |
|
|
| |
2007 |
|
| Equity holders of the Parent |
|
|
| Translation reserve |
14 |
|
| Actuarial gains and losses |
–263 |
|
| Minority interest |
– |
|
| Total |
–250 |
|
Consolidated Cash Flow Statement

| MSEK |
Note |
2007 |
2006 |
| |
32 |
|
|
| Operating activities |
|
|
|
| Profit before income tax |
|
2,662 |
3,173 |
| Adjustments for non-cash items and other |
|
120 |
110 |
| Income tax paid |
|
–410 |
–1,732 |
| |
|
|
|
| Cash flow from operating activities before |
|
|
|
| changes in working capital |
|
2,372 |
1,551 |
| |
|
|
|
| Cash flow from changes in working capital |
|
|
|
| Increase (–)/ Decrease (+) in inventories |
|
59 |
–97 |
| Increase (–)/Decrease (+) in operating receivables |
|
–122 |
–185 |
| Increase (+)/Decrease (–) in operating liabilities |
|
18 |
65 |
| Net cash from operating activities |
|
2,327 |
1,335 |
| |
|
|
|
| Investing activities |
|
|
|
| Purchase of property, plant and equipment* |
|
–541 |
–304 |
| Proceeds from sale of property, plant and equipment |
|
1,165 |
100 |
| Purchase of intangible assets |
|
–68 |
–270 |
| Acquisition of subsidiaries, net of cash acquired |
|
–1,209 |
–29 |
| Proceeds from sale of subsidiaries, net of cash disposed of |
|
– |
31 |
| Change in non-current receivables |
|
112 |
–60 |
| Change in other current investments |
|
51 |
277 |
| Net cash used in investing activities |
|
–490 |
–255 |
| |
|
|
|
| Financing activities |
|
|
|
| Repurchase of own shares |
|
–2,575 |
–3,674 |
| Stock options exercised |
|
122 |
94 |
| Proceeds from non-current borrowings |
|
2,239 |
5,512 |
| Repayment of borrowings |
|
–437 |
–2,383 |
| Dividends paid to equity holders of the Parent |
|
–664 |
–627 |
| Other |
|
–111 |
–86 |
| Net cash used in financing activities |
|
–1,426 |
–1,164 |
| |
|
|
|
| Net increase/decrease in cash and cash equivalents |
|
410 |
–85 |
| Cash and cash equivalents at the beginning of the year |
|
3,042 |
3,325 |
| Effect of exchange rate fluctuations on cash and cash equivalents |
|
–13 |
–198 |
| Cash and cash equivalent at end of year |
|
3,439 |
3,042 |
| * Includes investments in assets held for sale and biological assets. |
|
|
|